Overview

Iron Deficiency In Pulmonary Hypertension

Status:
Unknown status
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
Patients with idiopathic pulmonary arterial hypertension (IPAH) and iron deficiency were previously shown to have a decreased six-minute walking distance. Therefore the investigators hypothesized that intravenous iron administration would improve exercise capacity in iron deficient IPAH patients. 30 patients will be recruited for iron infusions. At baseline and after 12 weeks (endpoint)exercise test will be performed.
Phase:
Phase 4
Details
Lead Sponsor:
VU University Medical Center
Collaborator:
Vifor Pharma
Treatments:
Iron